UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 25, 2013
_______________________________
HYDROMER, INC.
(Exact name of registrant as specified in its charter)
_______________________________
| New Jersey | 001-31238 | 22-2303576 |
| (State or Other Jurisdiction | (Commission | (I.R.S. Employer |
| of Incorporation) | File Number) | Identification No.) |
35 Industrial Parkway, Branchburg,
N.J. 08876
(Address of Principal Executive Offices) (Zip Code)
(908) 722-5000
(Registrant’s
telephone number, including area code)
Not Applicable
(Former name or
former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item | 8.01 Other Events |
Press Release Announcing Hydromer, Inc. Entering Into Two Medical Coating Licenses
EXHIBIT INDEX
| Exhibit No. | Description |
| 99.50 | Press Release Issued February 25, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: February 26, 2013 | Hydromer, Inc | |
| By | /s/ Robert Y. Lee | |
| Name: Robert Y. Lee Title: Chief Financial Officer |
||